5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.88▼ | 0.88▼ | 0.88▼ | 0.88▲ | 0.74▲ |
MA10 | 0.89▼ | 0.88▼ | 0.88▲ | 0.85▲ | 0.95▼ |
MA20 | 0.89▼ | 0.87▲ | 0.87▲ | 0.75▲ | 1.37▼ |
MA50 | 0.87▲ | 0.86▲ | 0.86▲ | 0.98▼ | 1.30▼ |
MA100 | 0.87▲ | 0.84▲ | 0.79▲ | 1.44▼ | 2.80▼ |
MA200 | 0.86▲ | 0.76▲ | 0.81▲ | 1.29▼ | 3.04▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.000▼ | 0.000▼ | 0.038▲ | -0.067▼ |
RSI | 48.895▼ | 53.208▲ | 55.342▲ | 51.481▲ | 41.792▼ |
STOCH | 49.908 | 33.086 | 48.125 | 79.592 | 18.102▼ |
WILL %R | -72.000 | -69.104 | -36.218 | -15.960▲ | -76.500▼ |
CCI | -43.343 | -35.827 | 43.372 | 71.365 | -58.578 |
Tuesday, April 29, 2025 05:00 AM
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of ...
|
Tuesday, April 29, 2025 05:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
|
Sunday, April 27, 2025 05:00 PM
CUPERTINO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 0.8801 | 0.8801 | 0.8801 | 0.8801 | 5,318 |
01/05/25 | 0.89 | 0.9179 | 0.8691 | 0.8726 | 316,770 |
30/04/25 | 0.89 | 0.89 | 0.828 | 0.89 | 243,438 |
29/04/25 | 0.8703 | 0.8979 | 0.8509 | 0.8663 | 277,272 |
28/04/25 | 0.86 | 0.89 | 0.84 | 0.87 | 368,500 |
25/04/25 | 0.885 | 0.885 | 0.8052 | 0.8552 | 718,659 |
24/04/25 | 0.87 | 0.92 | 0.83 | 0.90 | 597,000 |
23/04/25 | 0.79 | 0.90 | 0.77 | 0.86 | 661,500 |
22/04/25 | 0.74 | 0.78 | 0.70 | 0.76 | 419,100 |
21/04/25 | 0.79 | 0.80 | 0.72 | 0.75 | 424,100 |
|
|
||||
|
|
||||
|
|